Plain-English translation of NCT06772168 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 3 โ Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a medication called CMG190303, which combines two treatments into one pill to help manage both type 2 diabetes and high cholesterol. Researchers want to see if this combination approach works better than taking the two medicines separately. The trial will also check that the medication is safe and well-tolerated.
Many people with type 2 diabetes also struggle with high cholesterol, and managing both conditions often means taking multiple pills. This trial is exploring whether combining two effective treatments into a single medication could make treatment simpler and potentially more effective for patients dealing with both conditions.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you qualify, you'll visit the clinic several times over about 6 months. You'll go through a screening visit, then a preparation period where you may stop certain medications temporarily and make dietary changes, followed by randomization into one of three groups: one receiving the new combination medication, one receiving one component with a placebo, or one receiving the other component with a placebo. You'll take your assigned medication daily and have regular blood tests to measure your blood sugar and cholesterol levels, plus check-ins about any side effects.
AI-generated summary from trial data ยท Jun 10, 2026 ยท Not medical advice
South Korea